Abstract
Many risk assessment tools have been developed for prostate cancer patients. The risk classifications, for example, the D’Amico classification and NCCN classification, are widely used. In addition, a nomogram to predict pathological stage and prognosis has also been developed. In this chapter, J-CAPRA score for all stage of patients treated by androgen depletion therapy is explained in detail.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
D’Amico AV, Whittington R, Malkowicz BS, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or internal radiation therapy for clinically localized prostate cancer. JAMA. 1998;280:969–74.
https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf
Japanese Urological Association Edit. Clinical practice guideline for prostate cancer. Tokyo: Medical Review Co., Ltd.; 2016.
Partin AW, Kattan MW, Subong EN, et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA. 1997;227:1445–51.
Naito S, Kuroiwa K, Kinukawa N, et al. Validation of Partin tables and development of a preoperative nomogram for Japanese patients with clinically localized prostate cancer using 2005 International Society of Urological Pathology consensus on Gleason grading: data from the Clinicopathological Research Group for Localized Prostate Cancer. J Urol. 2008;180:904–9.
Stephenson AJ, Scardino PT, Eastham JA, Bianco FJ Jr, Dotan ZA, Fearn PA, Kattan MW. Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Natl Cancer Inst. 2006;98(10):715–7.
Tanaka A, Ohori M, Paul L, Yu C, Kattan MW, Ohno Y, Tachibana M. External validation of preoperative nomograms predicting biochemical recurrence after radical prostatectomy. Jpn J Clin Oncol. 2013;43(12):1255–60.
Yeung VH, Chiu Y, SS Y, WH A, Chan SW. Are preoperative Kattan and Stephenson nomograms predicting biochemical recurrence after radical prostatectomy applicable in the Chinese population? ScientificWorldJournal. 2013;2013:506062. https://doi.org/10.1155/2013/506062.
Sobin LH, Gospodarowicz MK, Wittekind C, editors. TNM classification of malignant tumours. 7th ed. New York, NY: Wiley-Blackwell; 2011. ISBN: 978-1-4443-5896-4.
Kimura T, Onozawa M, Miyazaki J, Kawai K, Nishiyama H, Hinotsu S, Akaza H. Validation of the prognostic grouping of the seventh edition of the tumor-nodes-metastasis classification using a large-scale prospective cohort study database of prostate cancer treated with primary androgen deprivation therapy. Int J Urol. 2013;20(9):880–8.
Cooperberg MR, Hinotsu S, Namiki M, Ito K, Broering J, Carroll PR, Akaza H. Risk assessment among prostate cancer patients receiving primary androgen deprivation therapy. J Clin Oncol. 2009;27(26):4306–13.
Cooperberg MR, Pasta DJ, Elkin EP, et al. The University of California, San Francisco cancer of the prostate risk assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy. J Urol. 2005;173:1938–42.
Kitagawa Y, Hinotsu S, Shigehara K, Nakashima K, Kawaguchi S, Yaegashi H, Mizokami A, Akaza H, Namiki M. Japan cancer of the prostate risk assessment for combined androgen blockade including bicalutamide: clinical application and validation. Int J Urol. 2013;20(7):708–14.
Cooperberg MR, Hinotsu S, Namiki M, Carroll PR, Akaza H. Trans-Pacific variation in outcomes for men treated with primary androgen-deprivation therapy (ADT) for prostate cancer. BJU Int. 2016;117(1):102–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Hinotsu, S. (2018). Risk Assessment Among Patients Receiving Primary ADT for Prostate Cancer. In: Arai, Y., Ogawa, O. (eds) Hormone Therapy and Castration Resistance of Prostate Cancer. Springer, Singapore. https://doi.org/10.1007/978-981-10-7013-6_3
Download citation
DOI: https://doi.org/10.1007/978-981-10-7013-6_3
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-7012-9
Online ISBN: 978-981-10-7013-6
eBook Packages: MedicineMedicine (R0)